Antioxidants in cancer therapy: Is there a rationale to recommend antioxidants during cancer therapy?

BioFactors

Volumn 17, Issue 1-4, 2003, Pages 229-240

  Biesalski, Hans Konrad ^a   Frank, Jürgen ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTIESTROGEN; ANTIOXIDANT; BLEOMYCIN; CISPLATIN; DAUNORUBICIN; DIETHYLSTILBESTROL; DOXORUBICIN; MITOMYCIN C; PACLITAXEL; TAMOXIFEN;

CANCER RADIOTHERAPY; CANCER THERAPY; CONFERENCE PAPER; GENE THERAPY; HUMAN; HYPERTHERMIA; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0142075877     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520170122     Document Type: Conference Paper

References (81)

1. P. Kovacic, J.A. Osuna, Jr. Mechanisms of anti-cancer agents: emphasis on oxidative stress and electron transfer, Curr. Pharm. Des 6 (2000), 277-309.
2. S. Nair, E.P. Norkus, H. Hertan, C.S. Pitchumoni, Serum and colon mucosa micronutrient antioxidants: differences between adenomatous polyp patients and controls, Am. J. Gastroenterol. 96 (2001), 3400-3405.
3. G. Maiani, G. Pappalardo, A. Ferro-Luzzi, A. Raguzzini, E. Azzini, A. Guadalaxara, M. Trifero, T. Frommel and S. Mobarhan, Accumulation of beta-carotene in normal colorectal mucosa and colonic neoplastic lesions in humans, Nutr. Cancer 24 (1995), 23-31.
4. M.E. Begin, Effects of polyunsaturated fatty acids and of their oxidation products on cell survival, Chem. Phys. Lipids 45 (1987), 269-313.
5. M.E. Begin, G. Ells and D.F. Horrobin, Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation, J. Natl. Cancer Inst. 80 (1988), 188-194.
6. U.N. Das, M.E. Begin, G. Ells, Y.S. Huang and D.F. Horrobin, Polyunsaturated fatty acids augment free radical generation in tumor cells in vitro, Biochem. Biophys. Res. Commun. 145 (1987), 15-24.
7. C. Lhuillery, S. Cognault, E. Germain, M.L. Jourdan and P. Bougnoux, Suppression of the promoter effect of polyunsaturated fatty acids by the absence of dietary vitamin E in experimental mammary carcinoma, Cancer Lett. 114 (1997), 233-234.
8. L.W. Oberley and G.R. Buettner, Role of superoxide dismutase in cancer: a review, Cancer Res. 39 (1979), 1141-1149.
9. L.W. Oberley and T.D. Oberley, Role of antioxidant enzymes in cell immortalization and transformation, Mol. Cell Biochem. 84 (1988), 147-153.
10. L.W. Oberley, Anticancer therapy by overexpression of superoxide dismutase, Antioxid. Redox. Signal. 3 (2001), 461-472.
11. S.X. Skapek, O.M. Colvin, O.W. Griffith, D.R. Groothuis, E.V. Colapinto, Y. Lee, J. Hilton, G.B. Elion, D.D. Bigner and H.S. Friedman, Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts, Biochem. Pharmacol. 37 (1988), 4313-4317.
12. D. Labriola and R. Livingston, Possible interactions between dietary antioxidants and chemotherapy, Oncology (Huntingt) 13 (1999), 1003-1008.
13. R.A. Gatenby, H.B. Kessler, J.S. Rosenblum, L.R. Coia, P.J. Moldofsky, W.H. Hartz and G.J. Broder, Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy, Int. J. Radiat. Oncol. Biol. Phys. 14 (1988), 831-838.
14. K.A. Kennedy, Hypoxic cells as specific drug targets for chemotherapy, Anticancer Drug Des 2 (1987), 181-194.
15. 2 predicts survival in advanced cancer of the uterine cervix, Radiother. Oncol. 26 (1993), 45-50.
16. M. Nordsmark, M. Overgaard and J. Overgaard, Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck, Radiother. Oncol. 41 (1996), 31-39.
17. J.S. Daniels, K.S. Gates, C. Tronche and M.M. Greenberg, Direct evidence for bimodal DNA damage induced by tirapazamine, Chem. Res. Toxicol. 11 (1998), 1254-1257.
18. W.E. Wung and S.B. Howell, Hypoxanthine concentrations in normal subjects and patients with solid tumors and leukemia, Cancer Res. 44 (1984), 3144-3148.
19. T.M. Buttke and PA. Sandstrom, Oxidative stress as a mediator of apoptosis, Immunol. Today 15 (1994), 7-10.
20. G. Minotti, Sources and role of iron in lipid peroxidation, Chem. Res. Toxicol. 6 (1993), 134-146.
21. R. Roots and S. Okada, Estimation of life times and diffusion distances of radicals involved in x-ray-induced DNA strand breaks of killing of mammalian cells, Radiat. Res. 64 (1975), 306-320.
22. A.T.al Kazwini, P. O'Neill, G.E. Adams and E.M. Fielden, Radiation-induced energy migration within solid DNA: the role of misonidazole as an electron trap, Radiat. Res. 121 (1990), 149-153.
23. V. Darley-Usmar, H. Wiseman and B. Halliwell, Nitric oxide and oxygen radicals: a question of balance, FEBS Lett. 369 (1995), 131-135.
24. C.B. Brezden, R.A. McClell and A.M. Rauth, Mechanism of the selective hypoxic cytotoxicity of 1-methyl-2-nitroimidazole, Biochem. Pharmacol. 48 (1994), 361-370.
25. H. Sies, Biochemistry of oxidative stress, Angew. Chemie Int. Edition 25 (1986), 1058-1071.
26. A.H. Nias, Radiation and platinum drug interaction, Int. J. Radiat. Biol. Relat Stud. Phys. Chem. Med. 48 (1985), 297-314.
27. S.R. Chatterjee, H. Possel, T.S. Srivastava, J.P. Kamat, G. Wolf and T.P. Devasagayam, Photodynamic effects induced by meso-tetrakis[4-(carboxymethyleneoxy)phenyl] porphyrin on isolated Sarcoma 180 ascites mitochondria, J. Photochem. Photobiol. B 50 (1999), 79-87.
28. C. Salet and G. Moreno, Photosensitization of mitochondria. Molecular and cellular aspects, J. Photochem. Photobiol. B 5 (1990), 133-150.
29. J.R. Shulok, M.H. Wade and C.W. Lin, Subcellular localization of hematoporphyrin derivative in bladder tumor cells in culture, Photochem. Photobiol. 51 (1990), 451-457.
30. M.C. Luna, A. Ferrario, S. Wong, A.M. Fisher and C.J. Gomer, Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter, Cancer Res. 60 (2000), 1637-1644.
31. L. Flohe, R. Brigelius-Flohe, C. Saliou, M.G. Traber and L. Packer, Redox regulation of NF-kappa B activation, Free Radic. Biol. Med. 22 (1997), 1115-1126.
32. C.K. Sen and L. Packer, Antioxidant and redox regulation of gene transcription, FASEB J. 10 (1996), 709-720.
33. S. Grether-Beck, S. Olaizola-Horn, H. Schmitt, M. Grewe, A. Jahnke, J.P. Johnson, K. Briviba, H. Sies and J. Krutmann, Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene, Proc. Natl. Acad. Sci. USA, 93 (1996), 14586-14591.
34. L.O. Klotz, K. Briviba and H. Sies, Singlet oxygen mediates the activation of JNK by UVA radiation in human skin fibroblasts, FEBS Lett. 408 (1997), 289-291.
35. J. Tao, J.S. Sanghera, S.L. Pelech, G. Wong and J.G. Levy, Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative, J. Biol. Chem 271 (1996), 27107-27115.
36. S.M. Keyse, An emerging family of dual specificity MAP kinase phosphatases, Biochim. Biophys. Acta 1265 (1995), 152-160.
37. K. Scharffetter-Kochanek, M. Wlaschek, P. Brenneisen, M. Schauen, R. Blaudschun and J. Wenk, UV-induced reactive oxygen species in photocarcinogenesis and photoaging, Biol. Chem. 378 (1997), 1247-1257.
38. H. Hug, S. Strand, A. Grambihler, J. Galle, V. Hack, W. Stremmel, P.H. Krammer and P.R. Galle, Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells, J. Biol. Chem. 272 (1997), 28191-28193.
39. H. Masuda, T. Tanaka, U. Takahama, Cisplatin generates superoxide anion by interaction with DNA in a cell-free system, Biochem. Biophys. Res. Commun, 203 (1994), 1175-1180.
40. R. Uslu and B. Bonavida, Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum, Cancer 77 (1996), 725-732.
41. S.A. Shellard, L.K. Hosking and B.T. Hill, Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro, Cancer Res. 51 (1991), 4557-4564.
42. A. Miyajima, J. Nakashima, K. Yoshioka, M. Tachibana, H. Tazaki and M. Murai, Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells, Br. J. Cancer 76 (1997), 206-210.
43. A. Miyajima, J. Nakashima, M. Tachibana, K. Nakamura, M. Hayakawa and M. Murai, N-acetylcysteine modifies cis-dichlorodiammineplatinum-induced effects in bladder cancer cells, Jpn. J. Cancer Res. 90 (1999), 565-570.
44. A. Yokomizo, M. Ono, H. Nanri, Y. Makino, T. Ohga, M. Wada, T. Okamoto, J. Yodoi, M. Kuwano and K. Kohno, Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide, Cancer Res. 55 (1995), 4293-4296.
45. S.A. Park, K.S. Choi, J.H. Bang, K. Huh and S.U. Kim, Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand, J. Neurochem. 75 (2000), 946-953.
46. F.P. Hamers, J.H. Brakkee, E. Cavalletti, M. Tedeschi, L. Marmonti, G. Pezzoni, J.P. Neijt and W.H. Gispen, Reduced glutathione protects against cisplatin-induced neurotoxicity in rats, Cancer Res. 53 (1993), 544-549.
47. J.F. Smyth, A. Bowman, T. Perren, P. Wilkinson, R.J. Prescott, K.J. Quinn and M. Tedeschi, Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial, Ann. Oncol. 8 (1997), 569-573.
48. J. Tarasiuk, K. Tkaczyk-Gobis, B. Stefanska, M. Dzieduszycka, W. Priebe, S. Martelli and E. Borowski, The role of structural factors of anthraquinone compounds and their quinone-modified analogues in NADH dehydrogenase-catalysed oxygen radical formation, Anticancer Drug Des 13 (1998), 923-939.
49. D.J. Taatjes, D.J. Fenick, G. Gaudiano and T.H. Koch, A redox pathway leading to the alkylation of nucleic acids by doxorubicin and related anthracyclines: application to the design of antitumor drugs for resistant cancer, Curr. Pharm. Des 4 (1998), 203-218.
50. J.C. Schisselbauer, M. Crescimanno, N. D'Alessandro, M. Clapper, S. Toulmond, H. Tapiero and K.D.Tew, Glutathione, glutathione S-transferases, and related redox enzymes in Adriamycin-resistant cell lines with a multidrug resistant phenotype, Cancer Commun. 1 (1989), 133-139.
51. J. Vasquez-Vivar, P. Martasek, N. Hogg, B.S. Masters, K.A. Pritchard, Jr., and B. Kalyanaraman, Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin, Biochemistry 36 (1997), 11293-11297.
52. S.V. Kalivendi, S. Kotamraju, H. Zhao, J. Joseph and B. Kalyanaraman, Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium, J. Biol. Chem. 276 (2001), 47266-47276.
53. S.S. Legha, Y.M. Wang, B. Mackay, M. Ewer, G.N. Hortobagyi, R.S. Benjamin and M.K.Ali, Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity, Ann. N.Y. Acad. Sci. 393(411-8) (1982), 411-418.
54. S. Weitzman, B. Lorell and R. Carey, Prospective study of tocopherol prophylaxis for anthracycline cardiac toxicity, Curr. Ther. Res. 28 (1980), 682-686.
55. H.G. Keizer, H.M. Pinedo, G.J. Schuurhuis and H. Joenje, Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity, Pharmacol. Ther. 47 (1990), 219-231.
56. B.K. Sinha, Free radicals in anticancer drug pharmacology, Chem. Biol. Interact. 69 (1989), 293-317.
57. H.O. Pae, C.D. Jun, J.C. Yoo, H.J. Kwak, S.J. Lee, Y.A. Kook, R.K. Park and H.T. Chung, Enhancing and priming of macrophages for superoxide anion production by taxol, Immunopharmacol.Immunotoxicol. 20 (1998), 27-37.
58. M. Marone, G. D'Andrilli, N. Das, C. Ferlini, S. Chatterjee and G. Scambia, Quercetin abrogates taxol-mediated signaling by inhibiting multiple kinases, Exp. Cell Res. 270 (2001), 1-12.
59. G. Nicolini, R. Rigolio, M. Miloso, A.A. Bertelli and G. Tredici, Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line, Neurosci. Lett. 302 (2001), 41-44.
60. S.S. Dehal and D. Kupfer, Evidence that the catechol 3,4-Dihydroxytamoxifen is a proximate intermediate to the reactive species binding covalently to proteins, Cancer Res. 56 (1996), 1283-1290.
61. H. Wei, Q. Cai, L. Tian and M. Lebwohl, Tamoxifen reduces endogenous and UV light-induced oxidative damage to DNA, lipid and protein in vitro and in vivo, Carcinogenesis 19 (1998), 1013-1018.
62. R. Schiff, P. Reddy, M. Ahotupa, E. Coronado-Heinsohn, M. Grim, S.G. Hilsenbeck, R. Lawrence, S. Deneke, R. Herrera, G.C. Chamness, S.A. Fuqua, P.H. Brown and C.K. Osborne, Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo, J. Natl. Cancer Inst. 92 (2000), 1926-1934.
63. K. Mizumoto, P.A. Glascott, Jr., and J.L. Farber, Roles for oxidative stress and poly(ADP-ribosyl)ation in the killing of cultured hepatocytes by methyl methanesulfonate, Biochem. Pharmacol. 46 (1993), 1811-1818.
64. P.J. Dandliker, R.E. Holmlin and J.K. Barton, Oxidative thymine dimer repair in the DNA helix, Science 275 (1997), 1465-1468.
65. Q. Chen and J.L. Stevens, Inhibition of iodoacetamide and t-butylhydroperoxide toxicity in LLC-PK1 cells by antioxidants: a role for lipid peroxidation in alkylation induced cytotoxicity, Arch. Biochem. Biophys. 284 (1991), 422-430.
66. M.L. Freeman, M.J. Borrelli, K. Syed, G. Senisterra, D.M. Stafford and J.R. Lepock, Characterization of a signal generated by oxidation of protein thiols that activates the heat shock transcription factor, J. Cell Physiol 164 (1995), 356-366.
67. R.A. Kroes, K. Abravaya, J. Seidenfeld and R.I. Morimoto, Selective activation of human heat shock gene transcription by nitrosourea antitumor drugs mediated by isocyanate-induced damage and activation of heat shock transcription factor, Proc. Natl. Acad. Sci. USA, 88 (1991), 4825-4829.
68. P. Allevi, M. Anastasia, F. Cajone, P. Ciuffreda and A.M. Sanvito, Structural requirements of aldehydes produced in LPO for the activation of the heat-shock genes in HeLa cells, Free Radic. Biol. Med. 18 (1995), 107-116.
69. H. Liu, R. Lightfoot and J.L. Stevens, Activation of heat shock factor by alkylating agents is triggered by glutathione depletion and oxidation of protein thiols, J. Biol. Chem. 271 (1996), 4805-4812.
70. W.C. Dewey, L.E. Hopwood, S.A. Sapareto and L.E. Gerweck, Cellular responses to combinations of hyperthermia and radiation, Radiology 123 (1977), 463-474.
71. C. Streffer, Molecular and cellular mechanisms of hyperthermia, in: Thermoradiotherapy and Thermochemotherapy, M.H. Segenschmiedt, M. Fessenden, C.C. Vernon eds, Springer-Verlag, Berlin, 1995, pp. 47-74.
72. J.L. Skibba, E.J. Quebbeman and J.H. Kalbfleisch, Nitrogen metabolism and lipid peroxidation during hyperthermic perfusion of human livers with cancer, Cancer Res. 46 (1986), 6000-6003.
73. P.S. Lin, S. Quamo, K.C. Ho and J. Gladding, Hyperthermia enhances the cytotoxic effects of reactive oxygen species to Chinese hamster cells and bovine endothelial cells in vitro, Radiat. Res. 126 (1991), 43-51.
74. R.H. Powers, A. Stadnicka, J.H. Kalbfleish and J.L. Skibba, Involvement of xanthine oxidase in oxidative stress and iron release during hyperthermic rat liver perfusion, Cancer Res. 52 (1992), 1699-1703.
75. J.L. Skibba and E.A. Gwartney, Liver hyperthermia and oxidative stress: role of iron and aldehyde production, Int. J. Hyperthermia 13 (1997), 215-226.
76. T. Yoshikawa, S. Kokura, K. Tainaka, K. Itani, H. Oyamada, T. Kaneko, Y. Naito and M. Kondo, The role of active oxygen species and lipid peroxidation in the antitumor effect of hyperthermia, Cancer Res. 53 (1993), 2326-2329.
77. D.K. Kelleher and P. Vaupel, Tumor microenvironment: characterization and significance for hyperthermia treatment, Exptl. Oncol. 17 (1995), 256-268.
78. P. Vaupel, Pathophysiological mechanisms of hyperthermia in cancer therapy, in: Biological Basis of Oncologic Thermotherapy, M. Gautherie ed., Springer-Verlag, Berlin, 1990, pp. 73-134.
79. J. Frank, D.K. Kelleher, A. Pompella, O. Thews, H.K. Biesalski and P. Vaupel, Enhancement of oxidative cell injury and antitumor effects of localized 44 degrees C hyperthermia upon combination with respiratory hyperoxia and xanthine oxidase, Cancer Res. 58 (1998), 2693-2698.
80. P. Huang, L. Feng, E.A. Oldham, M.J. Keating and W. Plunkett, Superoxide dismutase as a target for the selective killing of cancer cells, Nature 407 (2000), 390-395.
81. L.D. Stegman, H. Zheng, E.R. Neal, O. Ben Yoseph, L. Pollegioni, M.S. Pilone and B.D. Ross, Induction of cytotoxic oxidative stress by D-alanine in brain tumor cells expressing Rhodotorula gracilis D-amino acid oxidase: a cancer gene therapy strategy, Hum. Gene Ther. 9 (1998), 185-193.